Skip to main content

Table 1 Demographic and clinical characteristics at the time of starting therapy for the 438 study patients

From: Therapy duration and long-term outcomes in extra-pulmonary tuberculosis

Variable

 Total

Major site of tuberculosis disease

p-value

 

N=438 (%)

Lymph nodes n=163(%)

Bone and joint n=92 (%)

GUS n=24 (%)

Meninges n=55 (%)

Peritoneum n=43 (%)

Other n=61 (%)

 

Age (years)

49(18)

47(18)

52(19)

48(17)

43(15)

49(16)

52(19)

0.02

Male

224(51)

76(47)

46(50)

15(63)

31(56)

23(54)

33(54)

0.63

Race

       

0.02

White

216(49)

73(45)

46(50)

20(83)

24(44)

21(49)

32(53)

 

Black

213(49)

85(52)

45(49)

3(13)

31(56)

22(51)

27(44)

 

Other

9(2)

5(3)

1(1)

1(4)

0

0

2(3)

 

Ethnicity

       

0.39

Hispanic

123(28)

42(26)

25(27)

11(46)

14(25)

11(26)

20(33)

 

Non-Hispanic

315(72)

121(74)

67(73)

13(54)

41(75)

32(74)

41(67)

 

Residence

        

Jail

29(7)

14(9)

5(5)

1(4)

2(4)

2(5)

5(8)

0.83

Nursing home

18(4)

8(5)

2(2)

1(4)

3(5)

1(2)

3(5)

0.86

Homeless

13(3)

3(2)

1(1)

1(4)

4(7)

1(2)

3(5)

0.19

Substance abuse

      

Alcohol

48(11)

17(10)

8(9)

2(8)

3(5)

11(26)

7(11)

0.07

Injection

15(3)

4(2)

6(7)

0

1(2)

4(9)

0

0.06

Other non-injection

35(8)

18(11)

5(5)

2(8)

2(4)

5(12)

3(5)

0.33

HIV-infected

93(21)

52(32)

5(5)

1(4)

16(29)

6(14)

13(21)

<0.001

Prior TB

15(3)

3(2)

4(4)

3(13)

1(2)

2(5)

2(3)

0.15

Acid-fast bacilli stain

74(17)

37 (23)

11 (12)

6(25)

4(7)

6(14)

10(16)

<0.001

Mtb culture

308(70)

131(80)

72(78)

16(67)

22(40)

30(70)

37(61)

<0.001

Completion of therapy

       

0.08

Completed

346(79)

133(82)

74(80)

21(88)

36(65)

33(77)

49(80)

 

Not completed

53(12)

15(9)

12 (13)

3(13)

8(15)

5(12)

10(16)